Related Experiment Video

Updated: May 15, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

Can a systems biology approach unlock the mysteries of Kawasaki disease?

Anne H Rowley1

  • 1Department of Pediatrics, Northwestern University Feinberg School of Medicine, The Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA. a-rowley@northwestern.edu

Wiley Interdisciplinary Reviews. Systems Biology and Medicine
|January 8, 2013
PubMed

Insights

Kawasaki disease (KD) is a childhood inflammatory illness affecting coronary arteries. Understanding its cause requires a systems biology approach, integrating genetic and infectious factors to find new treatments.

Area of Science:

  • Pediatric rheumatology
  • Infectious diseases
  • Genetics

Background:

  • Kawasaki disease (KD) is a critical childhood illness causing systemic inflammation, primarily impacting coronary arteries.
  • KD can lead to severe complications like coronary artery aneurysms, myocardial infarction, and sudden death.
  • While an infectious cause is suspected, the exact etiology of KD remains unknown, with recent evidence pointing towards a novel virus.

Purpose of the Study:

  • To explore the complex pathogenesis of Kawasaki disease.
  • To identify potential therapeutic targets for managing coronary artery abnormalities in KD patients.
  • To highlight the challenges and propose advanced methodologies for KD research.

Main Methods:

  • Review of clinical, epidemiologic, and pathological features of Kawasaki disease.
  • Examination of genetic susceptibility factors, including ethnic variations in incidence.
  • Proposal of a systems biology approach integrating genomics, proteomics, transcriptomics, and bioinformatics.

Main Results:

  • Genetic factors significantly influence KD susceptibility, with higher incidence in Asian populations.
  • A three-process model of KD vasculopathy has been proposed, aiding understanding of arterial immune responses.
  • Identification of immune response genes associated with KD susceptibility and outcomes.

Conclusions:

  • A comprehensive systems biology approach is crucial for unraveling the mysteries of Kawasaki disease pathogenesis.
  • Understanding the interplay of genetic predisposition and potential infectious triggers is key.
  • Developing novel therapeutic strategies requires a deeper insight into the immune-mediated arterial damage in KD.

More Related Videos

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...